NVISION'S INSIGHTS AT CELLULAR LEVEL ALLOW EARLIEST ASSESSMENT OF RESPONSE TO CANCER THERAPY.

One of the key issues in today's cancer therapy. THERE ARE MORE THERAPY OPTIONS THAN TIME TO TRY THEM. METABOLIC MRI PROVIDES UNPRECEDENTED INSIGHTS AT CELLULAR LEVEL. Differentiation between resistant and sensitive tumors within days by means of Metabolic MRI: Patients who are found to have resistant tumors can shift to a combination therapy or alternate drug, whereas patients who are found to have sensitive tumors can confidently continue with the sametreatment - but with certainty.

Metabolic MRI ushers in a new era. A NEW ERA OF ADAPTIVE CANCER TREATMENT, BASED ON EARLIEST ASSESSMENT OF METABOLIC RESPONSE